Treating antiretroviral-induced dyslipidemia in HIV-infected adults
Kristine Anne Scordo
Abstract
Kristine Anne Scordo
Abstract
In Brief Although limited information about the success of lipid-lowering therapy in HIV-infected patients is available from controlled studies, current guidelines support managing dyslipidemia in these patients similar to the general population per the National Cholesterol Education Program (NCEP) Adult Treatment Panel III guidelines.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In Brief Although limited information about the success of lipid-lowering therapy in HIV-infected patients is available from controlled studies, current guidelines support managing dyslipidemia in these patients similar to the general population per the National Cholesterol Education Program (NCEP) Adult Treatment Panel III guidelines.
Key concepts: Dyslipidemia, National Cholesterol Education Program, Human immunodeficiency virus (HIV), Antiretroviral therapy, Medicine, Population, Intensive care medicine, Internal medicine